Oral Cancer - Results of Treatment in the Copenhagen University Hospital

Abstract

Charabi B, Tørring H, Kirkegaard J, Hansen HS. Oral cancer-results of treatment in the Copenhagen Uni6ersity Hospital. Acta Otolaryngol 2000; Suppl 543: 246-247.During the period 1992-96, 304 patients with malignant tumours of the oral cavity were referred to the Department of Head & Heck Oncology, Copenhagen University Hospital. The female:male ratio was 1:2. Age ranged between 20 and 96 years, median 61 years. Ninety-five percent of the tumours were squamous cell carcinomas. Twenty-two percent were in stage I, 21% were in stage II, 21% were in stage III and 36% were in stage IV. Sixty percent of the patients underwent primary surgical resection, combined with reconstructive procedures if necessary. In 39% of all cases, surgery was followed by radiotherapy, while 21% of the patients, mainly stage I and II patients, were only treated surgically. Radiotherapy alone was received by 36% of the patients, mainly stage III and IV. Four percent of the patients received no treatment due to advanced disease or general poor condition. The overall recurrence rate was 42%, ranging from 23% in stage I to 61% in stage IV. Thirty-eight percent of these patients were treated for recurrence, almost exclusively by surgery. The survival rate 1 year after treatment of recurrence was 90%, 60% and 50% for patients in stage I, II and III respectively, while only 1 of 16 patients in stage IV was alive after 1 year. Three-year crude survival for the whole material was 42%, ranging from 58% in stage I to 18% in stage IV. This is an improvement of 12% compared with a similar group of patients treated in our departments in the period 1978-82, when the primary treatment of choice was external irradiation. The survival rate was, as expected, closely related to T-and N-stage at time of diagnosis. In conclusion, we recommend primary surgery followed by irradiation therapy for patients in stages II, III and IV. Surgical treatment of recurrence in patients who were formerly treated by irradiation therapy should be reserved for patients in good general condition and in a low TNM stage, stage IV patients will only benefit from salvage surgery in a few exceptional cases.

Oral Cancer Report from Northeastern Hungary

“…In our series we found a 5.2:1 ratio, consistent with other reports from Eastern Europe [10]. The median age of patients was 57.4 years, which is somewhat lower than in other regions [11][12][13][14]. This fact can be explained with the high (18.5%) frequency of patients younger than 45 years in our study population.…”

Características clínico-epidemológicas do carcinoma epidermóide de cavidade oral no sexo feminino

“…Em nosso estudo, esta proporção foi de 21,2% de pacientes do sexo feminino e 78,2% de pacientes do sexo masculino (1:4). Esta diferença na proporção da incidência entre homens e mulheres tem se reduzido a 1:2, quando a população estudada é mais recente 4 .…”

Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014

“…Surgery was the preferred treatment when radical excision of the tumor and possible lymph node metastases was possible, with acceptable esthetic and functional outcome [20]. This policy of managing OC with more surgery resulted in better survival [21]. During the study period, better radiation therapy techniques have been introduced, such as moderately accelerated radiotherapy [22], concurrent chemoradiotherapy, improved imaging and highly conformal radiotherapy.…”